NCICancerCommunity

Please Join us today at 3pm EDT for a talk on CRISPR-Cas9 Gene editing! Register at bit.ly/3MDLexu

If you are interested in discussing topics regarding cancer and the general public in clear language, check out the NCI CCP In The Know seminar series today at 3pm EDT. Register here at bit.ly/3MDLexu

The immunotherapy drug teclistamab (Tecvayli) was tested in patients that had undergone at least three different cancer treatments and almost 40% saw a complete remission. The drug was given accelerated approval last October by the FDA. bit.ly/3IJkJVg

📢 9 new #CancerGrandChallenges have been announced! Gather your team to apply for up to $25m in funding. Expressions of Interest are now open until June 22. Explore the challenges. ⏬ cancergrandchallenges.org/new-challenges… @‌CancerGrand

Is dual checkpoint inhibition an option for the management of patients with #HCC prior to liver transplantation? #LiverCancer #Immunotherapy @NCICCR_SurgOnc @AnnSurgOncol link.springer.com/article/10.124…

If you are considering treatment for cancer, here are some questions you may want to consider asking your doctor. cancer.gov/about-cancer/t…

The VHL gene was discovered by @theNCI and was the first gene linked to kidney cancer. More specifically, it has been linked to the most common type of kidney cancer, clear-cell renal cancer. Learn more at bit.ly/3ZcQn3a

The HPV vaccine protects against six kinds of cancer (cervical, anal, back of the throat, penile, vaginal, and vulvar) that are caused by infection with the human papillomavirus, or #HPV. Learn more about how to prevent infections. cancer.gov/about-cancer/c…  #AnalCancerAwarenessDay

If you are interested in discussing topics regarding cancer and the general public in clear language, check out the NCI CCP In The Know seminar series starting today at 3pm EDT. Register today at bit.ly/3TfYtGm and join at bit.ly/3yEOYah.

Register today for the CCP In the Know seminar series at  bit.ly/3TfYtGm and join the conversation at bit.ly/3yEOYah on Monday, March 20th at 3pm EDT.

The combination of two targeted drugs tucatinib (Tukysa) and trastuzumab (Herceptin) has been approved for advanced colorectal cancer that produces excess HER2 proteins. In #clinicaltrials, 38% of people saw tumor regression or disappearance. bit.ly/3gb9CsK

Want to learn more about the @theNCI Office of Cancer Survivorship (OCS)? Check out this About OCS page, which includes a downloadable fact sheet that highlights key survivorship-related statistics and funding opportunities. cancercontrol.cancer.gov/ocs/about #cancersurvivorship #survonc

Please join the NCI CCP Complimentary Care event: A Physical Health Perspective nih.zoomgov.com/j/1604470033?p…

#DYK? Acupuncture has been shown to help relieve certain side effects of anticancer therapies such as nausea, vomiting, fatigue, dry mouth, and hot flashes? Read more about this complementary medicine in this PDQ: bit.ly/acu-pdq

#CancerSurvivorship research seeks to enhance the health and well-being of all cancer survivors and caregivers. Learn more about the many aspects of cancer survivorship: cancercontrol.cancer.gov/ocs/definitions

#Hearingloss is a common side effect of some cancer treatments & can pose many challenges for #cancersurvivors. Join @NCICancerSurv on 1/24, 2pm ET for this OCS Director’s Series webinar w/ Dr. Dawn Konrad-Martin & Dr. Deborah Berndtson. cancercontrol.cancer.gov/ocs/about/even… @OHSUNews #survonc

DYK? Aromatherapy can be used with standard medical treatments to improve mood, anxiety, sleep, pain, and other cancer-related symptoms? See what the science has to say about aromatherapy and cancer here: bit.ly/aroma-cam

#DYK? @theNCI publishes up-to-date, evidence-based reports on complementary cancer care strategies? Take a peek at the link below! We'll be summarizing some of the most relevant insights from these "PDQ" summaries. bit.ly/cam-pdqs

Dietary supplements and herbs - when taken with an anticancer drug – could change the way the drug works, and may cause adverse effects and reactions? Read more about these complementary medicines in this PDQ: bit.ly/vit-c-pdq